$PATH

UiPath Stock Falls 17%; Its $13 Million Guide Raise Adds Just $0.2 Million to the Second Half

UiPath Inc. (NYSE: PATH) shares fell 16.63% to $15.19 despite beating quarterly revenue forecasts. The company raised its full-year revenue guidance by $13 million, but only $0.244 million is incremental for the second half. Q2 revenue was $410.256 million, up 13.4% YoY, with GAAP operating income of $31.6 million. Net new ARR declined to $37 million from $49 million in Q1. Analysts' average price target is $16.37, slightly above the current share price.

Original reporting
Published Sep 5, 2026, 10:15 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 5, 2026, 10:12 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
UiPath Stock Falls 17%; Its $13 Million Guide Raise Adds Just $0.2 Million to the Second Half — source image
Decision brief

The 30-second read

$PATHBearishMed
01

Why it matters

The earnings release introduced new guidance numbers and highlighted ARR slowdown, which are fresh data points for traders.

02

Market read

The earnings beat coupled with modest guidance caused a sharp sell‑off, signaling potential short‑term weakness in the RPA sector.

03

What to watch

Recent $268.5M share repurchase and improved GAAP profit margins could provide longer‑term support.

Relevance 8/10Novelty 8/10Timing: pre‑market today

Background

UiPath reported Q2 results with revenue beating forecasts and a small full‑year guidance increase, but the market reacted negatively due to limited incremental revenue outlook.

Company-level read

Ticker impact

$PATHBearishHigh confidence
Context

Q2 revenue beat and a modest $13M full-year guidance raise triggered a 16.6% stock drop to $15.19.

Expected impact

Further downside risk if ARR guidance remains weak; potential bounce if Q3 ARR acceleration materializes.

Evidence & confidence

The stock fell 16.6% on the day despite a revenue beat, indicating investors view the guidance as insufficient. The narrow incremental revenue outlook for H2 suggests near‑term earnings pressure.

Market effects

Highlights softness in the enterprise‑software automation sector and may pressure peers with similar ARR profiles.

U.S. tech stocks could see modest pullback as investors reassess guidance expectations.

Limited; primarily affects U.S. listed automation and RPA companies.

Counterpoint

The stock may be oversold; a modest guidance raise could be a floor if AI adoption accelerates in Q3‑Q4.

Key entities

  • UiPath Inc.

    Robotic process automation software provider.

  • Daniel Dines

    Founder and CEO of UiPath.

Related articles

$PATHMedAI 8/10

UiPath Just Sank 17%. Is the Stock a Buy on the Dip?

UiPath (PATH) shares fell 17% despite strong Q2 results and raised full-year guidance. Revenue grew 13% YoY to $410M, ARR rose 12% to $1.94B. The company is transitioning to AI integration, with 18 of 20 largest deals including AI components. It forecasts Q3 revenue of $440M-$445M and raised FY revenue guidance to $1.789B-$1.794B.

$NVDAHighAI 8/10

Consumer Tech (Aug 31-Sep 4): NVIDIA Buys World's Largest Open AI Developer, Trump Claims Total Control On Hormuz & More

NVIDIA (NVDA) agreed to acquire Hugging Face for $12.93B. Ambarella (AMBA), Asana (ASAN), Samsara (IOT), and others reported earnings beats. Dell (DELL) and Salesforce (CRM) saw strong AI-driven demand. NIO (NIO) missed revenue estimates. TSMC (TSM) raised chip equipment spending. Meta (META) opposed AI regulation. Broadcom (AVGO) and Microsoft (MSFT) expanded AI chip and reporting initiatives.

$PATHMedAI 8/10

UiPath Inc. Q2 2027 Earnings Call Summary

UiPath reported Q2 2027 earnings, highlighting platform evolution, AI integration, and strategic leadership changes. The company achieved GAAP profitability for the fourth consecutive quarter, with a 42% YoY reduction in stock-based compensation. Management expects coding agents to reduce implementation effort by 60% and anticipates FX headwinds of $18M in H2. Net retention rates are stabilizing, and the company is shifting to transaction-based pricing models. UiPath also announced a new develop

$PATHMedAI 8/10

Why UiPath Rallied in August

UiPath (PATH) shares surged 46.3% in August, despite no specific financial news, as analysts grew optimistic about the enterprise software sector. The rally was driven by resilient earnings from peers and raised price targets. UiPath reported Q2 revenue of $410.2M, up 13.3%, but shares fell 16.6% post-earnings due to flat EPS. The company trades at a low valuation with significant cash reserves.

$PATHHighAI 8/10

UiPath Q2 Earnings Call Highlights

UiPath reported Q2 revenue growth of 16% (normalized for FX), with cloud ARR exceeding $1.3B. AI-driven platform adoption led to larger customer expansions, including deals with a global insurer, the DoD, and a top Canadian bank. The company saw 109% net retention and forecasted Q3 revenue of $440M-$445M. UiPath also announced leadership changes and plans to detail its long-term strategy at an Investor Day.

$PATHMed

Why UiPath Stock Plunged Today

UiPath (NYSE: PATH) shares fell after its Q2 fiscal 2027 earnings, despite revenue growth of 13% to $410M and adjusted operating income up 43% to $89M. CEO Daniel Dines highlighted the company's strategy of using AI where it adds value. Analyst Kingsley Crane downgraded the stock to 'hold', citing competitive threats from AI-powered rivals like Salesforce.